Anticonvulsive effects of κ-Opioid receptor modulation in an animal model of ethanol withdrawal

Genes, Brain and Behavior

Volumn 5, Issue 6, 2006, Pages 483-496

  Beadles Bohling, A S ^a   Wiren, K M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Opioid receptor; 488H; Alcohol withdrawal induced seizure; Musmusculus; Nor binaltorphimine; Prodynorphin; U 50

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; ALCOHOL; KAPPA OPIATE RECEPTOR; NORBINALTORPHIMINE; PRODYNORPHIN;

ADAPTATION; ADOLESCENT; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; MALE; MOUSE; NERVE CELL EXCITABILITY; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; WITHDRAWAL SEIZURE;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ALCOHOL-INDUCED DISORDERS, NERVOUS SYSTEM; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; ANTICONVULSANTS; BRAIN; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; DRUG SYNERGISM; ETHANOL; MALE; NALTREXONE; RECEPTORS, OPIOID, KAPPA; SEIZURES; SPECIES SPECIFICITY; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

ANIMALIA;

EID: 33746865576     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2005.00200.x     Document Type: Article

References (33)

1. Baker, A.K. & Meert, T.F. (2002) Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice. J Pharmacol Exp Ther 302, 1253-1264.
2. Bausch, S.B., Esteb, T.M., Terman, G.W. & Chavkin, C. (1998) Administered and endogenously released kappa opioids decrease pilocarpine-induced seizures and seizure-induced histopathology. J Pharmacol Exp Ther 284, 1147-1155.
3. Beadles-Bohling, A.S. & Wiren, K.M. (2005) Alteration of kappa-opioid receptor system expression in distinct brain regions of a genetic model of enhanced ethanol withdrawal severity. Brain Res 1046, 77-89.
4. Beadles-Bohling, A.S., Crabbe, J.C. & Wiren, K.M. (2000) Elevated prodynorphin expression associated with ethanol withdrawal convulsions. Neurochem Int 37, 463-472.
5. Becker, H.C. & Veatch, L.M. (2002) Effects of lorazepam treatment for multiple ethanol withdrawals in mice. Alcohol Clin Exp Res 26, 371-380.
6. Broadbear, J.H., Negus, S.S., Butelman, E.R., de Costa, B.R. & Woods, J.H. (1994) Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay. Psychopharmacology (Berl) 115, 311-319.
7. Crabbe, J.C. & Kosobud, A.E. (1990) Alcohol withdrawal seizures: genetic animal models. In Porter, R.J., Mattson, R.H., Cramer, J.A., Diamond, I. & Schoenberg, D.G. (eds), Alcohol and Seizures. FA Davis Co., Philadelphia, pp. 126-139.
8. Crabbe, J.C., Kosobud, A. & Young, E.R. (1983) Genetic selection for ethanol withdrawal severity: differences in replicate mouse lines. Life Sci 33, 955-962.
9. Crabbe, J.C., Kosobud, A., Young, E.R., Tam, B.R. & McSwigan, J.D. (1985) Bidirectional selection for susceptibility to ethanol withdrawal seizures in Mus musculus. Behav Genet 15, 521-536.
10. Crabbe, J.C., Feller, D.J., Terdal, E.S. & Merrill, C.D. (1990a) Genetic components of ethanol responses. Alcohol 7, 245-248.
11. Crabbe, J.C., Phillips, T.J., Kosobud, A. & Belknap, J.K. (1990b) Estimation of genetic correlation: interpretation of experiments using selectively bred and inbred animals. Alcohol Clin Exp Res 14, 141-151.
12. Crabbe, J.C., Merrill, C. & Belknap, J.K. (1991) Acute dependence on depressant drugs is determined by common genes in mice. J Pharmacol Exp Ther 257, 663-667.
13. Endoh, T., Matsuura, H., Tanaka, C. & Nagase, H. (1992) Norbinaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo. Arch Int Pharmacodyn Ther 316, 30-42.
14. Gallaher, E.J., Jones, G.E., Belknap, J.K. & Crabbe, J.C. (1996) Identification of genetic markers for initial sensitivity and rapid tolerance to ethanol-induced ataxia using quantitative trait locus analysis in BXD recombinant inbred mice. J Pharmacol Exp Ther 277, 604-612.
15. Goldstein, D.B. (1972) Relationship of alcohol dose to intensity of withdrawal signs in mice. J Pharmacol Exp Ther 180, 203-215.
16. Goldstein, D.B. & Pal, N. (1971) Alcohol dependence produced in mice by inhalation of ethanol: grading the withdrawal reaction. Science 172, 288-290.
17. Himmelsbach, C.K. (1943) With reference to physical dependence. Fed Proc 2, 201-203.
18. Kai, T., Onishi, H., Koide, S., Katayama, M. & Yamagami, S. (1998) Developmental and regional alteration of kappa-opioid receptors in seizure-susceptible EL mouse brain. Neurochem Res 23, 163-168.
19. Kieffer, B.L. & Gaveriaux-Ruff, C. (2002) Exploring the opioid system by gene knockout. Prog Neurobiol 66, 285-306.
20. Koob, G.F. & Nestler, E.J. (1997) The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci 9, 482-497.
21. Kovacs, K.M., Szakall, I., O'Brien, D., Wang, R., Vinod, K.Y., Saito, M., Simonin, F., Kieffer, B.L. & Vadasz, C. (2005) Decreased oral self-administration of alcohol in kappa-opioid receptor knock-out mice. Alcohol Clin Exp Res 29, 730-738.
22. Lee, R.J., Bajorek, J.G. & Lomax, P. (1984) Similar anticonvulsant, but unique, behavioural effects of opioid agonists in the seizure-sensitive Mongolian gerbil. Neuropharmacology 23, 517-524.
23. Lee, R.J., Hong, J.S., McGinty, J.F. & Lomax, P. (1987) Increased enkephalin and dynorphin immunoreactivity in the hippocampus of seizure sensitive Mongolian gerbils. Brain Res 401, 353-358.
24. Loskota, W.J., Lomax, P. & Rich, S.T. (1974) The gerbil as a model for the study of the epilepsies. Seizure patterns and ontogenesis. Epilepsia 15, 109-119.
25. McClearn, G.E., Wilson, J.R. & Meredith, W. (1970) The use of isogenic and heterogenic mouse stocks in behavioral research. In Lindzey, G. & Thiessen, D. (eds), Contributions to Behavior Genetic Analysis: the Mouse as a Prototype. Appleton-Century-Crofts, New York, pp. 3-22.
26. McSwigan, J.D., Crabbe, J.C. & Young, E.R. (1984) Specific ethanol withdrawal seizures in genetically selected mice. Life Sci 35, 2119-2126.
27. Ploj, K., Roman, E., Gustavsson, L. & Nylander, I. (2000) Basal levels and alcohol-induced changes in nociceptin/orphanin FQ, dynorphin, and enkephalin levels in C57BL/6J mice. Brain Res Bull 53, 219-226.
28. Przewlocka, B., Lason, W., Machelska, H., van Luijtelaar, G., Coenen, A. & Przewlocki, R. (1995) Kappa opioid receptor agonists suppress absence seizures in WAG/Rij rats. Neurosci Lett 186, 131-134.
29. Przewlocka, B., Turchan, J., Lason, W. & Przewlocki, R. (1997) Ethanol withdrawal enhances the prodynorphin system activity in the rat nucleus accumbens. Neurosci Lett 238, 13-16.
30. Simonato, M. & Romualdi, P. (1996) Dynorphin and epilepsy. Prog Neurobiol 50, 557-583.
31. Simonin, F., Valverde, O., Smadja, C., Slowe, S., Kitchen, I., Dierich, A., Le Meur, M., Roques, B.P., Maldonado, R. & Kieffer, B.L. (1998) Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal. EMBO J 17, 886-897.
32. Tortella, F.C. & DeCoster, M.A. (1994) Kappa opioids: therapeutic considerations in epilepsy and CNS injury. Clin Neuropharmacol 17, 403-416.
33. Yajima, Y., Narita, M., Takahashi-Nakano, Y., Misawa, M., Nagase, H., Mizoguchi, H., Tseng, L.F. & Suzuki, T. (2000) Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse. Brain Res 862, 120-126.